Panitumumab-IRDye800
Panitumumab-IRDye800 is a pharmaceutical drug with 9 clinical trials. Currently 6 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
6
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Clinical Trials (9)
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9